Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan;70(1):221-222.
doi: 10.1136/gutjnl-2020-320876. Epub 2020 Apr 6.

Chronic liver disease negatively affects outcome in hospitalised patients with community-acquired pneumonia

Carla Bellinghausen  1 , Mathias W Pletz  2   3 , Jan Rupp  3   4 , Martin Witzenrath  3   5 , Christoph Welsch  6 , Stefan Zeuzem  7 , Jonel Trebicka  8   9 , Gernot G U Rohde  1   10 ; Members of the CAPNETZ study group
Collaborators, Affiliations
Comment

Chronic liver disease negatively affects outcome in hospitalised patients with community-acquired pneumonia

Carla Bellinghausen et al. Gut. 2021 Jan.
No abstract available

Keywords: bacterial infection; chronic liver disease.

PubMed Disclaimer

Conflict of interest statement

Competing interests: MW received research funding outside the submitted work from Biotest, Boehringer Ingelheim, Noxxon, Quark Pharma, Silence Therapeutics and Vaxxilon, and personal fees for lectures or counselling from Actelion, AstraZeneca, Bayer HealthCare, Berlin Chemie, Biotest, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Novartis and Vaxxilon. SZ received consultancy and/or lecture honoraria from AbbVie, Allergan, Intercept, Janssen, Gilead and Merck/MSD. JT received speaking and/or consulting fees from Gore, Bayer, Alexion, MSD, Gilead, Intercept, Norgine, Grifols, Versantis and Martin Pharmaceutical, all unrelated to the submitted work. GGUR reports personal fees from Pfizer, Boehringer Ingelheim, Solvay, GSK, Essex Pharma, MSD, Grifols, Chiesi, Vertex, Roche, Insmed and Novartis for lectures including service on speakers' bureaus outside the submitted work and/or consultancy during advisory board meeting, and personal fees from GSK for travel accommodations/meeting expenses outside the submitted work.

Comment on

LinkOut - more resources